Pain makes me anxious, and anxiety gives me pain

doi:10.1017/9781108623872.017

Case 17: - Pain makes me anxious, and anxiety gives me pain

Published online by Cambridge University Press: 03 April 2024

Daniel Jackson and

Sutanaya Pal

Edited by

Nevena V. Radonjić ,

Thomas L. Schwartz and

Stephen M. Stahl

Show author details

Nevena V. Radonjić: Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz: Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl: Affiliation:
University of California, San Diego

Book contents

Get access

Summary

What are the most common, evidence-based treatments for FM with comorbid psychiatric conditions?

Keywords

fibromyalgia major depressive disorder neuropathic pain sertraline (Zoloft)citalopram (Celexa)alprazolam (Xanax)duloxetine (Cymbalta)gabapentin (Neurontin)pregabalin (Lyrica)amitriptyline (Elavil)naltrexone (ReVia)sodium oxybate (Xyrem)milnacipran (Savella)

Type: Chapter
Information: Case Studies: Stahl's Essential Psychopharmacology , pp. 283 - 308

DOI: https://doi.org/10.1017/9781108623872.017 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Subscription

Individual access

Subscriptions are only available for individuals and not institutional access. Subscribe now

References

Arnold, LM, Hess, EV, Hudson, JI, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191–7CrossRef Google Scholar PubMed

Arnold, LM, Rosen, A, Pritchett, YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119:5–15CrossRef Google Scholar PubMed

Beakley, B, Kaye, A, Kaye, A. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician 2015; 18:395–400Google Scholar PubMed

Bennett, RM, Kamin, M, Karim, R, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003; 114:537–45CrossRef Google Scholar

Boomershine, CS. Fibromyalgia: the prototypical central sensitivity syndrome. Curr Rheumatol Rev 2015; 11:131–45CrossRef Google Scholar PubMed

Borchers, AT, Gershwin, ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol 2015; 49:100–51CrossRef Google Scholar PubMed

Carville, SF, Arendt-Nielsen, L, Bliddal, H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67:536–41CrossRef Google Scholar PubMed

Clauw, DJ. Fibromyalgia: a clinical review. JAMA 2014; 311:1547–55CrossRef Google Scholar PubMed

da Rocha, AP, Mizzaci, CC, Nunes Pinto, ACP, et al. Tramadol for management of fibromyalgia pain and symptoms: systematic review. Int J Clin Pract 2020; 74:e13455CrossRef Google Scholar PubMed

Derry, S, Cording, M, Wiffen, PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2016; 9:CD011790Google Scholar PubMed

Gilron, I, Chaparro, LE, Tu, D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain 2016; 157:1532–40CrossRef Google Scholar PubMed

Jackson, D, Singh, S, Zhang-James, Y, et al. The effects of low dose naltrexone on opioid induced hyperalgesia and fibromyalgia. Front Psychiatry 2021; 12:593842CrossRef Google Scholar PubMed

Johnson, B, Ulberg, S, Shivale, S, et al. Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system. Discov Med 2014; 18:209–20Google Scholar PubMed

Koenig, J, Jarczok, MN, Ellis, RJ, et al. Two-week test–retest stability of the cold pressor task procedure at two different temperatures as a measure of pain threshold and tolerance. Pain Pract 2014; 14:E126–35CrossRef Google Scholar PubMed

Marangell, LB, Clauw, DJ, Choy, E, et al. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 2011; 152:31–7CrossRef Google Scholar PubMed

Moore, AR, Straube, S, Paine, J, et al. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010; 149:360–4CrossRef Google Scholar PubMed

Ramanathan, S, Panksepp, J, Johnson, B. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option? Psychosomatics 2012; 53:591–4CrossRef Google Scholar PubMed

Rico-Villademoros, F, Slim, M, Calandre, E. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother 2015; 15:1–28CrossRef Google Scholar PubMed

Russell, IJ, Kamin, M, Bennett, RM, et al. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000; 6:250–7CrossRef Google Scholar PubMed

Russell, IJ, Perkins, AT, Michalek, JE. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009; 60:299–309CrossRef Google Scholar PubMed

Russell, JI, Mease, PJ, Smith, TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136:432–44CrossRef Google Scholar PubMed

Schwartz, T. Practical Psychopharmacology: Basic to Advanced Principles, 1st edn. New York: Routledge, 2017CrossRef Google Scholar

Spaeth, M, Bennett, RM, Benson, BA, et al. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Ann Rheum Dis 2012; 71:935–42CrossRef Google Scholar PubMed

Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5. Cambridge: Cambridge University Press, 2021CrossRef Google Scholar

Thorpe, J, Shum, B, Moore, RA, et al. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev 2018; 2:CD010585Google Scholar PubMed

Toljan, K, Vrooman, B. Low-dose naltrexone (LDN) – review of therapeutic utilization. Med Sci (Basel) 2018; 6:82Google Scholar PubMed

Tzadok, R, Ablin, JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag 2020; 2020:6541798CrossRef Google Scholar PubMed

Walsh, NE, Schoenfeld, L, Ramamurthy, S, et al. Normative model for cold pressor test. Am J Phys Med Rehabil 1989; 68:6–11CrossRef Google Scholar PubMed

Welsch, P, Üçeyler, N, Klose, P, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev 2018; 2:CD010292Google Scholar PubMed

Wolfe, F. How to use the new American College of Rheumatology fibromyalgia diagnostic criteria. Arthritis Care Res (Hoboken) 2011; 63:1073–4CrossRef Google Scholar PubMed

Wolfe, F, Clauw, DJ, Fitzcharles, MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011; 38:1113–22CrossRef Google Scholar PubMed

Wolfe, F, Clauw, DJ, Fitzcharles, MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62:600–10CrossRef Google Scholar PubMed

Wolfe, F, Smythe, HA, Yunus, MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160–72CrossRef Google Scholar PubMed

Younger, J, Mackey, S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 2009; 10:663–72CrossRef Google Scholar PubMed

Younger, J, Noor, N, McCue, R, et al. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 2013; 65:529–38CrossRef Google Scholar PubMed